Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
推进基因组技术对抗传染病:绘制单细胞、个体宿主和全球人群的动态图
基本信息
- 批准号:10641432
- 负责人:
- 金额:$ 138.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
Clinical rebound following treatment with nirmatrelvir-ritonar has been reported. The incidence,
virology, and clinical consequence of this syndrome are not clear. The investigators will conduct
a study of nirmatrelvir-ritonavir rebound with the following objectives:
Objective 1: Determine the incidence and risk factors for symptomatic and asymptomatic
virologic rebound after nirmatrelvir-ritonavir therapy
Objective 2: Determine the duration and magnitude of virologic rebound and contagiousness of
symptomatic and asymptomatic rebound after nirmatrelvir-ritonavir therapy
Objective 3: Estimate the incidence of treatment-emergent drug resistance after rebound
Objective 4: Describe clinical outcomes with and without virologic rebound following
nirmatrelvir-ritonavir therapy in a real-world setting
By carrying out these objectives, the investigators will define the incidence of rebound after
nirmatrelvir-ritonavir and characterize the associated syndrome using quantitative measurement
of viral load, viral culture, and whole virus genome sequencing.
项目摘要/摘要
尼马瑞韦-利托纳治疗后的临床反弹已有报道。发病率,
这种综合征的病毒学和临床后果尚不清楚。调查人员将进行
尼马瑞韦-利托那韦反弹的研究目的如下:
目标1:确定有症状和无症状的发病率和危险因素
尼马瑞韦-利托那韦治疗后病毒学反弹
目标2:确定病毒学反弹的持续时间和幅度以及传染性
尼马瑞韦-利托那韦治疗后有症状和无症状的反弹
目的3:评估药物反弹后紧急耐药的发生率
目标4:描述有和没有病毒学反弹的临床结果
尼马瑞韦-利托那韦在真实环境中的治疗
通过实现这些目标,调查人员将定义反弹的发生后
尼马瑞韦-利托那韦及其相关综合征的定量研究
病毒载量、病毒培养和全病毒基因组测序。
项目成果
期刊论文数量(159)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences.
整个醋酸杆菌属的基因组多样化:起源、机制和后果。
- DOI:10.1093/gbe/evu225
- 发表时间:2014-10-13
- 期刊:
- 影响因子:3.3
- 作者:Touchon M;Cury J;Yoon EJ;Krizova L;Cerqueira GC;Murphy C;Feldgarden M;Wortman J;Clermont D;Lambert T;Grillot-Courvalin C;Nemec A;Courvalin P;Rocha EP
- 通讯作者:Rocha EP
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.
- DOI:10.1038/ng.3767
- 发表时间:2017-03
- 期刊:
- 影响因子:30.8
- 作者:Manson AL;Cohen KA;Abeel T;Desjardins CA;Armstrong DT;Barry CE 3rd;Brand J;TBResist Global Genome Consortium;Chapman SB;Cho SN;Gabrielian A;Gomez J;Jodals AM;Joloba M;Jureen P;Lee JS;Malinga L;Maiga M;Nordenberg D;Noroc E;Romancenco E;Salazar A;Ssengooba W;Velayati AA;Winglee K;Zalutskaya A;Via LE;Cassell GH;Dorman SE;Ellner J;Farnia P;Galagan JE;Rosenthal A;Crudu V;Homorodean D;Hsueh PR;Narayanan S;Pym AS;Skrahina A;Swaminathan S;Van der Walt M;Alland D;Bishai WR;Cohen T;Hoffner S;Birren BW;Earl AM
- 通讯作者:Earl AM
Genomic characterization of recurrent mold infections in thoracic transplant recipients.
胸腔移植受者复发性霉菌感染的基因组特征。
- DOI:10.1111/tid.12935
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Messina,JuliaA;Wolfe,CameronR;Hemmersbach-Miller,Marion;Milano,Carmelo;Todd,JamieL;Reynolds,John;Alexander,BarbaraD;Schell,WileyA;Cuomo,ChristinaA;Perfect,JohnR
- 通讯作者:Perfect,JohnR
Field-deployable viral diagnostics using CRISPR-Cas13.
- DOI:10.1126/science.aas8836
- 发表时间:2018-04-27
- 期刊:
- 影响因子:0
- 作者:Myhrvold C;Freije CA;Gootenberg JS;Abudayyeh OO;Metsky HC;Durbin AF;Kellner MJ;Tan AL;Paul LM;Parham LA;Garcia KF;Barnes KG;Chak B;Mondini A;Nogueira ML;Isern S;Michael SF;Lorenzana I;Yozwiak NL;MacInnis BL;Bosch I;Gehrke L;Zhang F;Sabeti PC
- 通讯作者:Sabeti PC
The Anopheles coluzzii microbiome and its interaction with the intracellular parasite Wolbachia.
库氏按蚊微生物组及其与细胞内寄生虫沃尔巴克氏体的相互作用。
- DOI:10.1038/s41598-020-70745-0
- 发表时间:2020
- 期刊:
- 影响因子:4.6
- 作者:Straub,TimothyJ;Shaw,WRobert;Marcenac,Perrine;Sawadogo,SimonP;Dabiré,RochK;Diabaté,Abdoulaye;Catteruccia,Flaminia;Neafsey,DanielE
- 通讯作者:Neafsey,DanielE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce W. BIRREN其他文献
Bruce W. BIRREN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce W. BIRREN', 18)}}的其他基金
The 200 mammals project: sequencing genomes by a novel cost-effective method, yielding a high resolution annotation of the human genome
200 只哺乳动物项目:通过一种新颖的经济有效的方法对基因组进行测序,产生人类基因组的高分辨率注释
- 批准号:
10087672 - 财政年份:2020
- 资助金额:
$ 138.47万 - 项目类别:
The 200 mammals project: sequencing genomes by a novel cost-effective method, yielding a high resolution annotation of the human genome.
200 只哺乳动物项目:通过一种新颖的经济有效的方法对基因组进行测序,产生人类基因组的高分辨率注释。
- 批准号:
9173645 - 财政年份:2016
- 资助金额:
$ 138.47万 - 项目类别:
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
推进基因组技术对抗传染病:绘制单细胞、个体宿主和全球人群的动态图
- 批准号:
10610394 - 财政年份:2014
- 资助金额:
$ 138.47万 - 项目类别:
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
推进基因组技术对抗传染病:绘制单细胞、个体宿主和全球人群的动态图
- 批准号:
10470461 - 财政年份:2014
- 资助金额:
$ 138.47万 - 项目类别:
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
推进基因组技术对抗传染病:绘制单细胞、个体宿主和全球人群的动态图
- 批准号:
10447900 - 财政年份:2014
- 资助金额:
$ 138.47万 - 项目类别:
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
推进基因组技术对抗传染病:绘制单细胞、个体宿主和全球人群的动态图
- 批准号:
9919476 - 财政年份:2014
- 资助金额:
$ 138.47万 - 项目类别:
Infectious Disease Genomics: Pathogen Evolution, Emergence, and Host Interaction
传染病基因组学:病原体进化、出现和宿主相互作用
- 批准号:
8836963 - 财政年份:2014
- 资助金额:
$ 138.47万 - 项目类别:
Advancing Genomic Technologies to Combat Infectious Disease: Mapping Dynamics within Single Cells, Individual Hosts, and Global Populations
推进基因组技术对抗传染病:绘制单细胞、个体宿主和全球人群的动态图
- 批准号:
10381731 - 财政年份:2014
- 资助金额:
$ 138.47万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
- 批准号:
2734768 - 财政年份:2026
- 资助金额:
$ 138.47万 - 项目类别:
Studentship
Exploring the Impact of Clinical Diagnosis on Health and Education Outcomes for Children Receiving Special Educational Needs support for Autism
探索临床诊断对接受自闭症特殊教育需求支持的儿童的健康和教育结果的影响
- 批准号:
ES/Z502431/1 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Fellowship
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Fellowship
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Fellowship
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
- 批准号:
2412195 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Standard Grant
Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
- 批准号:
MR/Y014707/1 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Research Grant
Determining the clinical utility of BioEP: a multisite, prospective, study
确定 BioEP 的临床效用:一项多中心前瞻性研究
- 批准号:
10090508 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Investment Accelerator
VITAL: VIrtual Twins as tools for personalised clinicAL care
VITAL:虚拟双胞胎作为个性化临床护理的工具
- 批准号:
10106393 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
EU-Funded
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
量子脑成像:临床应用的途径
- 批准号:
10107115 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Small Business Research Initiative
Novel 'extended labour induction' balloon to improve safety of labour induction: Prototype development and preliminary clinical study
新型“延长引产”球囊可提高引产安全性:原型开发和初步临床研究
- 批准号:
MR/Y503423/1 - 财政年份:2024
- 资助金额:
$ 138.47万 - 项目类别:
Research Grant